JP2005536464A5 - - Google Patents

Download PDF

Info

Publication number
JP2005536464A5
JP2005536464A5 JP2004503475A JP2004503475A JP2005536464A5 JP 2005536464 A5 JP2005536464 A5 JP 2005536464A5 JP 2004503475 A JP2004503475 A JP 2004503475A JP 2004503475 A JP2004503475 A JP 2004503475A JP 2005536464 A5 JP2005536464 A5 JP 2005536464A5
Authority
JP
Japan
Prior art keywords
group
compound
halogen
different
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004503475A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005536464A (ja
Filing date
Publication date
Priority claimed from US10/139,817 external-priority patent/US6703399B2/en
Application filed filed Critical
Publication of JP2005536464A publication Critical patent/JP2005536464A/ja
Publication of JP2005536464A5 publication Critical patent/JP2005536464A5/ja
Pending legal-status Critical Current

Links

JP2004503475A 2002-05-06 2003-04-22 カンプトテシンのハロアルキルエステルおよびこれらの化合物を使用する癌治療方法 Pending JP2005536464A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/139,817 US6703399B2 (en) 2002-05-06 2002-05-06 Halo-alkyl esters of camptothecins and methods of treating cancer using these compounds
PCT/US2003/012650 WO2003095461A1 (en) 2002-05-06 2003-04-22 Halo-alkyl esters of camptothecins and methods of treating cancer using these compounds

Publications (2)

Publication Number Publication Date
JP2005536464A JP2005536464A (ja) 2005-12-02
JP2005536464A5 true JP2005536464A5 (https=) 2006-06-01

Family

ID=29399359

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004503475A Pending JP2005536464A (ja) 2002-05-06 2003-04-22 カンプトテシンのハロアルキルエステルおよびこれらの化合物を使用する癌治療方法

Country Status (6)

Country Link
US (1) US6703399B2 (https=)
EP (1) EP1501836A1 (https=)
JP (1) JP2005536464A (https=)
AU (1) AU2003231068A1 (https=)
CA (1) CA2484816C (https=)
WO (1) WO2003095461A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100723454B1 (ko) * 2004-08-21 2007-05-30 페어차일드코리아반도체 주식회사 높은 열 방출 능력을 구비한 전력용 모듈 패키지 및 그제조방법
US20040204435A1 (en) * 2003-04-09 2004-10-14 Joachim Liehr Alternating treatment with topoisomerase I and topoisomerase II inhibitors
US7517891B2 (en) * 2005-10-27 2009-04-14 Glyconix Corporation Camptothecin derivatives and improved synthetic methods
CN101522686A (zh) * 2006-08-11 2009-09-02 克里斯特斯斯特林癌症研究基金会 制备喜树碱酯的方法
WO2008070009A2 (en) * 2006-12-01 2008-06-12 Alza Corporation Treating solid tumors and monocytic leukemia using topoisomerase inhibitors in liposomes
US7572803B2 (en) * 2007-10-25 2009-08-11 The Christus Stehlin Foundation For Cancer Research Hydrated crystalline esters of camptothecin
CN102649795B (zh) * 2011-06-23 2014-08-06 东北林业大学 10-甲氧基喜树碱衍生物、制备方法和用途
US20130121921A1 (en) 2011-11-11 2013-05-16 The Christus Stehlin Foundation For Cancer Research Rodent Therapeutic Model And Methods
CN103864811A (zh) * 2012-12-13 2014-06-18 天津科技大学 一种新颖的10-羟基喜树碱20位衍生物制备方法及其在抗肿瘤药物中的应用
WO2025077773A1 (zh) * 2023-10-10 2025-04-17 上海翊维康医药有限责任公司 新的i型拓扑异构酶抑制剂及其制备方法和用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399282A (en) 1979-07-10 1983-08-16 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives
JPS5612393A (en) * 1979-07-10 1981-02-06 Yakult Honsha Co Ltd Novel camptothecin derivative
US5552154A (en) 1989-11-06 1996-09-03 The Stehlin Foundation For Cancer Research Method for treating cancer with water-insoluble s-camptothecin of the closed lactone ring form and derivatives thereof
US6080751A (en) 1992-01-14 2000-06-27 The Stehlin Foundation For Cancer Research Method for treating pancreatic cancer in humans with water-insoluble S-camptothecin of the closed lactone ring form and derivatives thereof
US5880131A (en) 1993-10-20 1999-03-09 Enzon, Inc. High molecular weight polymer-based prodrugs
US5965566A (en) 1993-10-20 1999-10-12 Enzon, Inc. High molecular weight polymer-based prodrugs
US5646159A (en) 1994-07-20 1997-07-08 Research Triangle Institute Water-soluble esters of camptothecin compounds
US5731316A (en) 1996-01-30 1998-03-24 The Stehlin Foundation For Cancer Research Derivatives of camptothecin and methods of treating cancer using these derivatives
US6407118B1 (en) 1996-01-30 2002-06-18 The Stehlin Foundation For Cancer Research Derivatives of camptothecin and methods of treating cancer using these derivatives
US6096336A (en) 1996-01-30 2000-08-01 The Stehlin Foundation For Cancer Research Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
US5922877A (en) 1997-08-05 1999-07-13 The Stehlin Foundation For Cancer Research Methods of preparing and purifying 9-nitro-20-camptothecin
US6228855B1 (en) 1999-08-03 2001-05-08 The Stehlin Foundation For Cancer Research Aromatic esters of camptothecins and methods to treat cancers
US6350756B1 (en) 2001-01-18 2002-02-26 California Pacific Medical Center Camptothecin derivatives
GB0119578D0 (en) 2001-08-10 2001-10-03 Pharmacia & Upjohn Spa Fluoro linkers

Similar Documents

Publication Publication Date Title
JP2005536464A5 (https=)
ES2569655T3 (es) Procedimientos para la producción de compuestos de (+)-'nal' morfinano
RU2009105669A (ru) Способ получения 3-замещенных 2-амино-5-галогенбензамидов
JP7400005B2 (ja) 細胞傷害性ベンゾジアゼピン誘導体の調製方法
ES2953833T3 (es) La invención se refiere a procedimientos de preparación de compuestos de benzoxacepina oxazolidinona e intermedios útiles
ES2933376T3 (es) Métodos de preparación de derivados de benzodiazepina citotóxicos
GB2056973A (en) Camptothecin derivatives useful as antitumour agents
CN112851646A (zh) 特戈拉赞的制备方法
JP2005529920A5 (https=)
CA2380022A1 (en) Aromatic esters of camptothecins and methods to treat cancers
CN1273974A (zh) 喜树碱衍生物,其制备方法和含它们的药物组合物
CA2484816A1 (en) Halo-alkyl esters of camptothecins and methods of treating cancer using these compounds
WO2022127321A1 (zh) 一种新型中间体及其制备方法和应用
CN111039893A (zh) 一种取代苯并噻唑c2芳基化衍生物的制备方法
US8796490B2 (en) Method of producing a triarylamine compound
JP2005529920A (ja) カンプトテシンのカスケードエステルおよびこれらの化合物を使用する癌治療方法
JP2010500350A (ja) カンプトテシンのエステルの製造法
CN110128345A (zh) 一种吡唑酮衍生物的制备方法
CN1761668A (zh) 具有抗肿瘤活性的喜树碱的7-亚氨基衍生物
CN1476435A (zh) 用作抗有丝分裂以及抗肿瘤药物的氟化喹诺酮
CN1793145A (zh) 7-位取代高喜树碱类化合物及作为药物的用途
CN1505622A (zh) 制备(二氧杂环戊烯酮-4-基)甲基酯衍生物的方法
CN113214205B (zh) 一种色原酮衍生物的制备方法
CN1167676C (zh) 单核对氯、对氟和对甲氧基苯甲酰异羟肟酸二烃基锡配合物的合成
CN1162404C (zh) 合成用于制备三环化合物的中间体的方法